Havelka photo copyPrincipal Investigators: Dr. George Havelka, Dr. Darwin Eton

Disease: Chronic limb-threatening ischemia

Research Description: Patients with Chronic Limb‐threatening Ischemia (CLI) suffer from impeded blood flow to their limbs. They present with foot pain, ulceration and/or gangrene. They require risky and costly revascularization operations to avoid amputation, although these surgeries are ineffective in many cases and amputations are sometimes required. Drs. Havelka and Eton have found that combining a compression device with a drug originally approved for use in cancer patients restored vascularization, significantly improves patient outcomes, eliminates the need for surgery and reduces amputation rates. This clinical study of CLI patients will describe the molecular effects of the repurposed treatment.

CWR funding role: Primary funder

CWR Start date: 2016

Sign up for our eNewsletter today!


First Name

Cures Within Reach


All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes.  CWR is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Wednesday the 21st. Copyright 2018 Cures Within Reach.